Jun 01, 2026
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
May 14, 2026
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
Mar 09, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
Mar 09, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
Mar 04, 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Feb 26, 2026
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Feb 18, 2026
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences